RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+15.06%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1B
AUM Growth
+$1B
(+7.9%)
Cap. Flow
-$31.8M
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
34.85%
Holding
100
New
15
Increased
28
Reduced
32
Closed
15
Top Buys
| 1 |
Medtronic
MDT
|
$17.8M |
| 2 |
Thermo Fisher Scientific
TMO
|
$17.5M |
| 3 |
Pfizer
PFE
|
$16.7M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$11.2M |
| 5 |
DexCom
DXCM
|
$8.07M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$24.6M |
| 2 |
CVS Health
CVS
|
$12.8M |
| 3 |
Eli Lilly
LLY
|
$12.8M |
| 4 |
Elevance Health
ELV
|
$11.8M |
| 5 |
McKesson
MCK
|
$11.6M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
76
DELISTED
IGM Biosciences
IGMS
| $1.66M | 0.17% |
200,000
| – | – |
|
77
Intellia Therapeutics
NTLA
$1.26B
| $1.52M | 0.15% |
50,000
| – | – |
|
78
Stryker
SYK
$149B
| $1.5M | 0.15% |
+5,000
| New | +$1.5M |
|
79
Acadia Healthcare
ACHC
$2.15B
| $1.45M | 0.14% |
+18,624
| New | +$1.45M |
|
80
Amgen
AMGN
$153B
| $1.3M | 0.13% |
+4,500
| New | +$1.3M |
|
81
Bio-Techne
TECH
$8.3B
| $1.23M | 0.12% |
16,000
-26,680
| -63% | -$2.06M |
|
82
Bruker
BRKR
$4.45B
| $1.18M | 0.12% |
+16,000
| New | +$1.18M |
|
83
Penumbra
PEN
$10.5B
| $629K | 0.06% |
+2,500
| New | +$629K |
|
84
Pulmonx
LUNG
$67.6M
| $319K | 0.03% |
+25,000
| New | +$319K |
|
85
MeiraGTx Holdings
MGTX
$590M
| $225K | 0.02% |
32,091
-506,895
| -94% | -$3.56M |
|
86
Allogene Therapeutics
ALLO
$249M
| – | – |
-300,000
| Closed | -$951K |
|
|
87
Becton Dickinson
BDX
$54.3B
| – | – |
-95,000
| Closed | -$24.6M |
|
88
BioNTech
BNTX
$24.1B
| – | – |
-53,000
| Closed | -$5.76M |
|
89
Edwards Lifesciences
EW
$47.7B
| – | – |
-29,000
| Closed | -$2.01M |
|
90
Harmony Biosciences
HRMY
$2.16B
| – | – |
-81,474
| Closed | -$2.67M |
|
91
Moderna
MRNA
$9.36B
| – | – |
-30,000
| Closed | -$3.1M |
|
92
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-16,000
| Closed | -$508K |
|
93
Outset Medical
OM
$245M
| – | – |
-3,333
| Closed | -$544K |
|
94
10x Genomics
TXG
$1.66B
| – | – |
-68,000
| Closed | -$2.81M |
|
95
Veeva Systems
VEEV
$44.4B
| – | – |
-23,000
| Closed | -$4.68M |
|
|
RCM
96
DELISTED
R1 RCM Inc. Common Stock
RCM
| – | – |
-300,000
| Closed | -$4.52M |
|
|
OLK
97
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| – | – |
-166,000
| Closed | -$2.45M |
|
|
KRTX
98
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-35,000
| Closed | -$5.92M |
|
|
IMGN
99
DELISTED
Immunogen Inc
IMGN
| – | – |
-700,000
| Closed | -$11.1M |
|
|
MRTX
100
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-175,000
| Closed | -$7.62M |
|